The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
web230614
Real-World Case Discussion: Intervene With Jakafi® (ruxolitinib) at Diagnosis in Adults With Intermediate- or High-Risk Myelofibrosis
Date
June 14, 2023
Explore related products in the following collection:
